Tag: Biotech and Pharmaceuticals

Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Regeneron weighs overseas price for Otarmeni, gene therapy for rare type of hearing loss

FDA fast-tracks psychedelic drug research following Trump executive order

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

RFK Jr. says he would support a potential ban on junk food TV ads

UnitedHealth tops quarterly estimates, hikes profit outlook as insurer manages high medical costs